Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.
KIRhub 2.0· v2Sign in
← Cases

SRMS

RBC: SRMS · Substrate: pEY + Mn · medium confidenceReferenceDerived

Top inhibitors

MeasuredDerived
DrugInhibition %Gini
Ponatinib100.00.53
Vemurafenib95.30.60
Dasatinib91.00.70
Ibrutinib89.70.72
Tivozanib85.20.67
Dabrafenib79.30.63
Cabozantinib74.50.75
Zanubrutinib54.00.79
Bosutinib52.60.55
Brigatinib45.00.51
Alectinib38.20.65
Encorafenib33.50.76
Repotrectinib31.10.61
Mobocertinib28.30.76
Canertinib23.60.67

Known variants

No variants catalogued.
Open in new tab